| BPH Global Ltd (BP8) ORDINARY FULLY PAID |
Health Care |
$5 |
Trading Results Rebound as Seasonal Conditions Improve
|
28 Apr 2026 9:42AM |
$0.002 |
$0.002 |
fallen by
0%
|
|
BP8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Gross sales of IDR 4,215,000,000 for the eleventh trading period.
- Month-on-month increase of approximately 68.1%.
- Aggregate gross sales of approximately A$2.94 million over eleven months.
- Improved trading conditions as the wet season ends.
- Stable demand across domestic and export markets.
- Focus on strengthening engagement with local farmer networks.
- Company positioned to increase purchasing from local farmers.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Raiz Invest Limited (RZI) ORDINARY FULLY PAID |
Financials |
$58 |
Q3 FY26 Quarterly Business Update
|
28 Apr 2026 9:41AM |
$0.560 |
$0.550 |
fallen by
1.79%
|
|
RZI - Price-sensitive ASX Announcement
Full Release
Key Points
- Active Customers increased to 340,222, up 4.7% YOY.
- Funds Under Management (FUM) reached $2.04 billion, up 23.6% YOY.
- Average Revenue Per User (ARPU) increased by 14.1% to $86.61.
- Super and Jars portfolios experienced strong growth, with Jars up 142.4% YOY.
- Raiz won two WeMoney Awards for Best for Round-Up Investing and Best for Kids Investing.
- Progress in AI-driven customer experience capabilities and product enhancements.
- Financial guidance for FY26 UEBITDA maintained between $4.5 million and $5.5 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Reach Resources Limited (RR1) ORDINARY FULLY PAID |
Materials |
$12 |
Application for quotation of securities - RR1
|
28 Apr 2026 9:40AM |
$0.009 |
$0.012 |
risen by
33.33%
|
|
| Connected Minerals Limited (CML) ORDINARY FULLY PAID |
Information Technology |
$16 |
Trading Halt
|
28 Apr 2026 9:40AM |
$0.340 |
$0.325 |
fallen by
4.41%
|
|
CML - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by Connected Minerals Limited.
- Awaiting announcement on acquisition and capital raising.
- Halt lasts until announcement or 30 April 2026 trading start.
- Complies with ASX Listing Rule 17.1.
- No known reasons against granting the halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Osmond Resources Limited (OSM) ORDINARY FULLY PAID |
Materials |
$63 |
High-Grade Assay Results Continue at Orion Project
|
28 Apr 2026 9:40AM |
$0.600 |
$0.455 |
fallen by
24.17%
|
|
OSM - Price-sensitive ASX Announcement
Full Release
Key Points
- Osmond Resources Limited has announced the final assay results from Phase 1 drilling at the Orión EU Critical Minerals Project.
- The drill holes NWOR-04bis, NWOR-01, NWOR-02, and SOR-01 highlight the project's potential to contain significant critical and strategic mineral resources, including zirconium, rare earth elements, and titanium.
- High-grade mineralization is confirmed over a ~10km distance from AV-01 to NWOR-04bis.
- Drill hole NWOR-02 identified the first intersection of the Basal Seam in the lower Pochico Formation, enhancing the project's regional prospectivity.
- Phase 2 drilling is scheduled to commence in the coming weeks.
- Quality control for assays involved standards, blanks, duplicates, and external laboratory checks, ensuring accuracy and precision.
- Mineralization includes heavy minerals such as rutile, ilmenite, zircon, and monazite.
- Assay highlights include significant percentages of TiO2 and ZrO2 along with various rare earth elements from multiple drill holes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| archTIS Limited (AR9) ORDINARY FULLY PAID |
Information Technology |
$42 |
Investor Webinar
|
28 Apr 2026 9:40AM |
$0.060 |
$0.087 |
risen by
45%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$59 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Apr 2026 9:38AM |
$0.165 |
$0.115 |
fallen by
30.30%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- Amplia Therapeutics Limited is developing narmafotinib, a FAK inhibitor, for fibrotic cancers like pancreatic cancer.
- The ACCENT trial showed narmafotinib with chemotherapy improved survival rates in pancreatic cancer patients.
- The AMPLICITY trial, exploring narmafotinib with FOLFIRINOX, faced challenges with dose-limiting toxicity.
- Amplia's cash position is strong with $27.9 million as of March 2026, despite $3.5 million in net operating cash outflows.
- Significant funds were allocated to research, development, and administration costs.
- Large-scale production of narmafotinib to GMP standards has been completed, enhancing readiness for Phase 3 trials.
- The company is focusing on regulatory engagement with the US FDA and planning new clinical studies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Muzinich BDC Income Fund - Active ETF (BDCI) MUZINICH BDC INCOME FUND - ACTIVE ETF |
- |
$2 |
Distribution for month ending 30 April 2026
|
28 Apr 2026 9:38AM |
$19.910 |
$19.600 |
fallen by
1.56%
|
|
| Switzer Dividend Growth Fund (Managed Fund) (SWTZ) |
Financials |
$55 |
Distribution for month ending 30 April 2026
|
28 Apr 2026 9:38AM |
$2.460 |
$2.390 |
fallen by
2.85%
|
|
| Energy Resources of Australia Limited (ERA) ORDINARY FULLY PAID 'A' |
Energy |
$811 |
Appendix 3Y - Brad Welsh
|
28 Apr 2026 9:36AM |
$0.004 |
$0.002 |
fallen by
42.86%
|
|
| Fortifai Ltd (FTI) ORDINARY FULLY PAID |
Communication Services |
$242 |
Further Benchmark Results Prove Infrastructure Cost Savings
|
28 Apr 2026 9:36AM |
$0.715 |
$0.705 |
fallen by
1.40%
|
|
FTI - Price-sensitive ASX Announcement
Full Release
Key Points
- FTI's Nol8 FPGA appliance can replace up to 60,000 CPUs for AI workloads.
- Nol8 delivers AI-grade data processing at significantly lower costs and footprint.
- Annual operating cost of the Nol8 is under A$37,000 compared to A$4.5m for CPUs.
- Further benchmark testing confirms infrastructure cost savings using Nol8.
- Nol8's technology addresses CPU bottlenecks in AI data processing.
- FortifAI Limited uses AI to enhance technology efficiencies and develop video games.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nexsen Limited (NXN) ORDINARY FULLY PAID |
Health Care |
$21 |
Quarterly Report - Q3 FY26
|
28 Apr 2026 9:35AM |
$0.215 |
$0.230 |
risen by
6.98%
|
|
NXN - Price-sensitive ASX Announcement
Full Release
Key Points
- Nexsen ended the quarter with $5.73 million in cash reserves.
- Secured AU$500,000 grant for neonatal diagnostics and HK$6 million IGNITE Grant for Hong Kong expansion.
- StrepSure® test for Group B Streptococcus progressing towards FDA submission by Q4 2026.
- Global rollout strategy for StrepSure® targeting Hong Kong, Malaysia, and India.
- Advancing towards ISO 13485 certification to support regulatory approvals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Finder Energy Holdings Limited (FDR) ORDINARY FULLY PAID |
Energy |
$190 |
Trading Halt
|
28 Apr 2026 9:34AM |
$0.590 |
$0.350 |
fallen by
40.68%
|
|
FDR - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by Finder Energy Holdings Limited.
- Trading halt is due to pending capital raising announcement.
- Halt in accordance with ASX Listing Rule 17.1.
- Expected to lift by normal trading on 30 April 2026.
- No known reason for halt not to be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Xamble Group Limited (XGL) CHESS DEPOSITARY INTERESTS 1:1 |
Communication Services |
$5 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Apr 2026 9:34AM |
$0.013 |
$0.010 |
fallen by
23.08%
|
|
XGL - Price-sensitive ASX Announcement
Full Release
Key Points
- Group revenue was A$1.64 million in Q1 CY2026, a decrease of 1% compared to the previous year.
- Underlying business EBITDA loss was A$0.17 million, reflecting higher operating costs.
- The Group received an A$306,000 drawdown from the Malaysian Digital Acceleration Grant.
- Cash flow from operating activities was almost neutral with a slight outflow of A$12,000.
- Three new commercial contracts in technology, education, and automotive sectors valued at A$1.17 million.
- Completion of 55.6% acquisition of YouthsToday, expanding influencer community.
- Adrian Tan appointed as Interim CEO to lead integration and AI transformation.
- Stable cash and cash equivalents at A$946,000 with additional credit facility available.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Oncosil Medical Limited (OSL) ORDINARY FULLY PAID |
Health Care |
$17 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Apr 2026 9:33AM |
$0.485 |
$0.550 |
risen by
13.40%
|
|
OSL - Price-sensitive ASX Announcement
Full Release
Key Points
- Q3 FY26 dose sales up 60% compared to the previous year.
- Number of commercially active treatment centres increased by 56% over the last year.
- Strategic initiatives expected to lower the cost base by $3.4-3.9 million annually from FY27.
- Germany G-BA Trial anticipated to start in Q4 FY26.
- Renzo DeCarlo appointed as Global Head of Manufacturing and Operations.
- Strong early clinical results in Türkiye with high surgical conversion rates.
- TRIPP-FFX Trial completed Last Patient, Last Visit (LPLV) with results expected in Q4 FY26.
- New manufacturing facility anticipated to be operational in 1H FY27.
- Comparative study shows survival and disease control benefits with OncoSil™ Therapy.
- $8 million capital raised and $1.8 million R&D tax incentive received.
- Strong cash position of $9.3 million as of 31 March 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lowell Resources Fund (LRT) ORDINARY UNITS FULLY PAID |
Financials |
$91 |
LRT NAV Estimate - 24 April 2026
|
28 Apr 2026 9:32AM |
$2.280 |
$2.190 |
fallen by
3.95%
|
|
| Spheria Emerging Companies Limited (SEC) ORDINARY FULLY PAID |
Financials |
$137 |
Net Tangible Asset Backing
|
28 Apr 2026 9:32AM |
$2.390 |
$2.280 |
fallen by
4.60%
|
|
| Constellation Technologies Limited (CT1) ORDINARY FULLY PAID |
Information Technology |
$4 |
Change in substantial holding
|
28 Apr 2026 9:31AM |
$0.003 |
$0.003 |
risen by
20%
|
|
| Skylark Minerals Limited (SKM) ORDINARY FULLY PAID |
Materials |
$32 |
Quarterly Activities Report
|
28 Apr 2026 9:31AM |
$0.270 |
$0.245 |
fallen by
9.26%
|
|
SKM - Price-sensitive ASX Announcement
Full Release
Key Points
- Maiden drilling program commenced at Zaranou Gold Project in Côte d'Ivoire.
- Initial drilling results confirm mineralisation extends significantly deeper and remains open in multiple directions.
- Zaranou project holds an inferred resource of 364,600 ounces of gold.
- Skylark is also advancing exploration at Maphai and Vavoua projects.
- Company is actively seeking new asset opportunities in West Africa.
- Recent capital raise maintains strong cash position for exploration activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PhosCo Ltd (PHO) ORDINARY FULLY PAID |
Materials |
$85 |
March 2026 Quarterly Activities and Cashflow Report
|
28 Apr 2026 9:31AM |
$0.130 |
$0.160 |
risen by
23.08%
|
|
PHO - Price-sensitive ASX Announcement
Full Release
Key Points
- Gasaat Phosphate Project in Tunisia supported by local communities and government
- KM and SAB prospects show promising phosphate mineralization
- Operating cash outflows of $714,000 and investing outflows of $501,000
- Net inflow of $4.67 million from financing activities
- Project strategically significant due to high-quality phosphate resources and location
- Phosphate critical for agriculture and battery production
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atomic Eagle Ltd (AEU) ORDINARY FULLY PAID |
Materials |
$136 |
Commencement of 30,000m drill program
|
28 Apr 2026 9:31AM |
$0.420 |
$0.355 |
fallen by
15.48%
|
|
AEU - Price-sensitive ASX Announcement
Full Release
Key Points
- Atomic Eagle Limited's 2026 drill program commenced at its Muntanga Uranium Project in Zambia.
- The drilling program targets 30,000 meters across three key areas: Chisebuka, Namakande, and Muntanga North.
- The program aims to expand the uranium resource base and test new exploration targets.
- The company reported a 24% increase in its total Mineral Resources to 58.8 million pounds of U3O8.
- The Chisebuka area will undergo infill drilling to convert known mineralization into a JORC-compliant Mineral Resource.
- Namakande and Muntanga North will see maiden drilling to explore new potential uranium deposits.
- Atomic Eagle is fully funded for its exploration programs in 2026 and 2027.
- The exploration will support Atomic Eagle's vision of developing a district-scale uranium mine.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cullen Resources Limited (CUL) ORDINARY FULLY PAID |
Materials |
$5 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Apr 2026 9:30AM |
$0.008 |
$0.007 |
fallen by
12.50%
|
|
CUL - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash used in operating activities was negative $375,000 for the quarter.
- Proceeds from the sale of non-current assets totaled $1,500,000.
- Advances from directors provided a net cash inflow of $110,000, with repayments of $170,000.
- Cash and cash equivalents at the end of the period were $609,000.
- Payments to related parties during the quarter totaled $81,000.
- The company plans to continue drilling activities at the Yardilla Gold Project.
- An access agreement has been signed for exploration at the Marymia Inlier project.
- No proceeds were raised from equity securities or convertible debt securities during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Horizon Gold Limited (HRN) ORDINARY FULLY PAID |
Materials |
$195 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Apr 2026 9:30AM |
$1.250 |
$1.000 |
fallen by
20%
|
|
HRN - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of deep diamond drilling at Kingfisher and Omega prospects.
- Initiation of resource expansion drilling at Eagle South and Goldfinch prospects.
- Advancement of the Gum Creek Feasibility Study, on schedule for H1 CY 2026.
- High-grade gold mineralization confirmed at Kingfisher.
- Capital raising of $30 million announced to support studies and exploration.
- Appointment of Scott Williamson as CEO and Managing Director.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Skylark Minerals Limited (SKM) ORDINARY FULLY PAID |
Materials |
$32 |
Quarterly Cashflow Report
|
28 Apr 2026 9:30AM |
$0.270 |
$0.245 |
fallen by
9.26%
|
|
SKM - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflow from operating activities was $647,000 for the quarter.
- No receipts from customers were recorded.
- Significant cash outflows in staff and administration costs.
- Investing activities saw a $1,139,000 outflow for exploration.
- Net cash outflow from investing activities for the nine months was $7,669,000.
- Financing activities raised $6,427,000 primarily through equity issuance.
- Cash balance at end of the period increased to $7,531,000.
- Payments to related parties for the quarter were $149,000.
- Estimated 4.2 quarters of funding available.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| H3 Energy Limited (H3E) ORDINARY FULLY PAID |
Energy |
$8 |
Trading Halt
|
28 Apr 2026 9:29AM |
$0.010 |
$0.007 |
fallen by
30%
|
|
H3E - Price-sensitive ASX Announcement
Full Release
Key Points
- H3 Energy Limited requested a trading halt on its shares.
- The halt is due to an upcoming announcement regarding Capital Raising.
- Trading halt remains until the announcement or 30 April 2026.
- The trading halt request is in accordance with ASX Listing Rule 17.1.
- Board of H3 Energy Limited approved the trading halt request.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
